Back to Search Start Over

Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

Authors :
Rakesh Popat
Bradley Augustson
Mercedes Gironella
Cindy Lee
Paul Cannell
Nashita Patel
Ravi S. Kasinathan
Rachel Rogers
Mehreen Shaikh
Amy Curry
Fernando Carreño
Sumita Roy-Ghanta
Joanna Opalinska
Hang Quach
Source :
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Publication Year :
2024
Publisher :
Nature Publishing Group, 2024.

Details

Language :
English
ISSN :
20445385
Volume :
14
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Blood Cancer Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.6e970035029749a08d3baafb531187a5
Document Type :
article
Full Text :
https://doi.org/10.1038/s41408-024-01155-y